BioPontis, Pfizer deal

Pfizer will provide guidance on BioPontis' product portfolio in-licensed from its university partners to help ensure that BioPontis invests in development programs that align with "clinical need and market demand." Pfizer will also evaluate and have opportunities to license "early-stage therapeutic opportunities." Terms were not disclosed. ...